Login

Stephen Streater: CEO of Forbidden Technologies | Stephen Streater , CEO at Forbidden Technologies plc 00:10:00

Share On Facebook Share On Twitter

The CEO of Forbidden Technologies plc is Stephen Streater.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Michael Barone Discusses the Evolution of Brokered Conventions
00:10:00
Time to Re-enter the Bond Market with ETFs? | BlackRock Bottom Line
00:10:00
CRU Insights: Super Cycles, Lithium Deficits, and the Future of Rare Earths in the Green Transition
00:10:00
Daniel Dines of UiPath presents 10 AI innovations poised to change lives at UiPath FORWARD VI 2023.
00:10:00
Dubai's Retail Boom: A Key Opportunity for Global Brands
00:10:00
Top 5 Questions on the Minds of Women Investors Today | Susan Olson - Financial Advisor of Abacus Wealth Partners
00:10:00
AGMO GROUP BMG20203-OPERATION MANAGEMENT | Aik Tan, CEO, Agmo Holdings BhdAGMO:KLS
00:10:00
Queensland Students Engage in Peatland Restoration with Australian Government Support
00:10:00
Metallurgical Coal Demand to Outstrip Supply: Coronado Global Resources | Douglas Thompson, CEO, Coronado Global Resources IncCRN:ASX
00:10:00
We have built a leading alternative asset management and retirement services platform by staying true to our core principles | Jim Zelter,Co-President, Apollo Asset Management,Leeds Group Plc
00:10:00
Empowering Local Talent: The ESS Manager-in-Training Program
00:10:00
Ryan Wilson: Expert Financial Planning and Wealth Management at Janney Montgomery Scott

© 2017 - Neuhu+